Endothelium-derived 2-arachidonylglycerol : An intermediate in vasodilatory eicosanoid release in bovine coronary arteries

• Published in: American journal of physiology. Heart and circulatory physiology Vol. 57; no. 3; pp. H1344 - H1351
• Main Authors: GAUTHIER, Kathryn M, BAEWER, David V, HITTNER, Sarah, HILLARD, Cecilia J, NITHIPATIKOM, Kasem, SUDARSHAN REDDY, D, FALCK, J. R, CAMPBELL, William B
• Format: Journal Article
• Language: English
• Published: Bethesda, MD American Physiological Society 01.03.2005
• Subjects: Acids; Biological and medical sciences; Circulatory system; Coronary vessels; Fundamental and applied biological sciences. Psychology; Vertebrates: cardiovascular system; Bovine; Prostaglandin I2; prostacyclin; Coronary artery; Ox; Arachidonic acid; endothelium-derived hyperpolarizing factor; epoxyeicosatrienoic acids; Endothelium; Relaxation; Vertebrata; Mammalia; Eicosanoid; Artiodactyla; Circulatory system; vascular relaxation; Ungulata; Release
• ISSN: 0363-6135; 1522-1539

Acetylcholine stimulates the release of endothelium-derived arachidonic acid (AA) metabolites including prostacyclin and epoxyeicosatrienoic acids (EETs), which relax coronary arteries. However, mechanisms of endothelial cell (EC) AA activation remain undefined. We propose that 2-arachidonylglycerol (2-AG) plays an important role in this pathway. An AA metabolite isolated from bovine coronary ECs was identified as 2-AG by mass spectrometry. In ECs pretreated with the fatty acid amidohydrolase inhibitor diazomethylarachidonyl ketone (DAK; 20 micro mol/l), methacholine (10 micro mol/l)-stimulated 2-AG release was blocked by the phospholipase C inhibitor U-73122 (10 micro mol/l) or the diacylglycerol lipase inhibitor RHC-80267 (40 micro mol/l). In U-46619-preconstricted bovine coronary arterial rings, 2-AG relaxations averaging 100% at 10 micro mol/l were inhibited by endothelium removal, by DAK, by the hydrolase inhibitor methyl arachidonylfluorophosphate (10 micro mol/l), by the cyclooxygenase inhibitor indomethacin (10 micro mol/l), but not by the CB1 cannabinoid receptor antagonist SR-141716 (1 micro mol/l). The cytochrome P-450 inhibitor SKF-525a (10 micro mol/l) and the 14,15-epoxyeicosa-5Z-enoic acid EET antagonist (14,15-EEZE; 10 micro; mol/l) further attenuated the indomethacin-resistant relaxations. The nonhydrolyzable 2-AG analogs noladin ether, 2-AG amide, and 14,15-EET glycerol amide did not induce relaxation. N-nitro-L-arginine-resistant relaxations to methacholine were also inhibited by U-73122, RHC-80267, and DAK. 14,15-EET glycerol ester increased opening of large-conductance K+ channels 12-fold in cell-attached patches of isolated smooth muscle cells and induced relaxations averaging 95%. These results suggest that methacholine stimulates EC 2-AG production through phospholipase C and diacylglycerol lipase activation. 2-AG is further hydrolyzed to AA, which is metabolized to vasoactive eicosanoids. These studies reveal a role for 2-AG in EC AA release and the regulation of coronary tone. [PUBLICATION ABSTRACT]